ArkeaBio vs Granular
Side-by-side comparison of AI visibility scores, market position, and capabilities
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
About
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
Corteva Agriscience (CTVA)-owned farm management platform for field operations, budgeting, and agronomic analytics; competing with Bayer FieldView and John Deere Operations Center for commercial farm data.
About
Granular is an agriculture farm management software platform that provides data-driven tools for farmers, agronomists, and agricultural enterprises to manage field operations, track crop performance, plan budgets, and analyze financial and agronomic outcomes — enabling modern farming operations to replace spreadsheets and paper-based records with integrated digital farm management. Originally acquired by DuPont Pioneer in 2017 and subsequently integrated into Corteva Agriscience (NYSE: CTVA, the agricultural chemicals and seeds company spun out of DowDuPont in 2019), Granular serves large commercial farming operations across the US.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.